A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma

Details for Australian Patent Application No. 2004298790 (hide)

Owner Octapharma AG

Inventors Romisch, Jurgen; Heger, Andrea; Marguerre, Wolfgang; Svae, Tor-Einar

Agent Davies Collison Cave

Pub. Number AU-B-2004298790

PCT Pub. Number WO2005/058334

Priority 03029359.1 19.12.03 EP

Filing date 20 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 8 April 2010

International Classifications

A61K 35/16 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Plasma

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058334 Priority application(s): WO2005/058334

8 April 2010 Application Accepted

  Published as AU-B-2004298790

5 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298792-Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients

2004298789-Stabilised compositions of factor VII polypeptides